Karen Wernli to Colorectal Neoplasms
This is a "connection" page, showing publications Karen Wernli has written about Colorectal Neoplasms.
Connection Strength
0.882
-
Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1230-7.
Score: 0.302
-
Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res. 2010 Aug; 20(4):305-9.
Score: 0.230
-
The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58.
Score: 0.076
-
Use of interactive voice response to improve colorectal cancer screening. Med Care. 2014 Jun; 52(6):496-9.
Score: 0.076
-
Common single-nucleotide polymorphisms in the estrogen receptor ß promoter are associated with colorectal cancer survival in postmenopausal women. Cancer Res. 2013 Jan 15; 73(2):767-75.
Score: 0.068
-
Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. Br J Cancer. 2011 Mar 01; 104(5):763-8.
Score: 0.060
-
Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk. World J Gastroenterol. 2009 May 21; 15(19):2336-9.
Score: 0.054
-
Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms. Nutr Cancer. 2011; 63(4):583-92.
Score: 0.015